Aziyo is a developer of customized tissue products intended to restore health and mobility to the greatest number of patients.
Aziyo is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. From our proprietary tissue processing platforms, we have developed a portfolio of advanced regenerative medical products that are designed to be very similar to natural biological material.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 15, 2022 | Post-IPO Debt | $4M | 1 | SWK Holdings | — | Detail |
Dec 1, 2022 | Post-IPO Equity | $11.20M | — | — | — | Detail |
Dec 6, 2021 | Post-IPO Equity | $14M | — | — | — | Detail |
Oct 8, 2020 | IPO | $50M | — | — | — | Detail |
Sep 11, 2020 | Series Unknown | $5.03M | — | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 16, 2022
Virtualness
|
Seed | $8M | Information Technology | — |
May 16, 2022
Smytten
|
Series B | ₹1B | Consumer | — |
May 11, 2022
GoKwik
|
Series B | $35M | Artificial Intelligence | — |
Feb 22, 2022
Slurrp Farm
|
Series Unknown | ₹520M | Food and Beverage | — |
Oct 9, 2019
Smytten
|
Series A | $1.50M | Consumer | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
SWK Holdings | Yes | Post-IPO Debt |
HighCape Partners | Yes | Series Unknown |
Deepfield | — | Series Unknown |
MidCap Financial | — | Series Unknown |